布普勒鲁姆通过抑制小鼠心室肌细胞中的L型通道来产生抗失律作用
Shuanglin Zhang1, Yuzhong Jia1, Guolan Ma1
1Institute of Cardiovascular Diseases, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology, Wuhan, 430065, China.
Biochemical and biophysical research communications
|December 1, 2023
概括
布普勒 (Bup) 通过抑制L型通道,减少心室动和心跳动的发生率,显示出抗心律不良的特性. 这项研究揭示了Bupup.
科学领域:
- 心血管药理学心血管药理学
- 电力生理学 电力生理学
- 传统中国医药 传统中国医药
背景情况:
- 布普勒鲁姆 (Bup) 是一种传统的草药,用于感冒和发烧.
- 布普表现出各种生物活动,包括心脏保护和抗炎作用.
- 布普对心脏电生理学的影响在很大程度上仍未被探索.
研究的目的:
- 为了研究布普勒鲁姆 (Bup) 对心脏电生理学的影响.
- 为了确定Bup.的抗心律失常潜力.
- 为了阐明Bup在心脏中的特定离子通道目标.
主要方法:
- 电心电图 (ECG) 记录被用来评估Bup对小鼠中阿科尼丁诱导的心律失常的影响.
- 采用贴片技术来分析Bup对心脏动作潜力 (AP) 和离子电流的影响.
- 研究的特定离子电流包括L型电流 (ICa.L),短暂的电流 (INa.T),晚期电流 (INa.L),短暂的向外电流 (Ito),延迟的整流电流 (IK) 和向内整流电流 (IK1).
主要成果:
- 布普勒鲁姆 (Bup) 显著降低了心室动 (VF) 的发生率,并延迟了心室低心率 (VT) 的发生.
- 布普抑制了延迟后去极化 (DADs) 和缩短了动作潜力的持续时间 (APD50和APD90).
- 布普剂量依赖地抑制了L型电流 (ICa.L) 并改变了它们的门动力学,但对其他主要离子电流没有显著影响.
结论:
- 布普勒 (Bup) 作为一种抗心律失常剂.
- 布普的抗心律失常作用很可能通过抑制L型通道来介导.
- 这些发现为Bup在心血管疾病中的传统使用提供了机制基础.
更多相关视频
相关概念视频
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
845
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
845
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
747
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
747
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.0K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.0K
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
528
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
528
01:26Heart Failure Drugs: Inotropic Agents
594
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
594